Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-10-17 5:00 pm Unchanged | 13D | LIPELLA PHARMACEUTICALS INC LIPO | Chancellor Michael B | 1,677,136 16.000% | 0 (Unchanged) | View |
| 2024-08-19 4:05 pm Purchase | 13D | LIPELLA PHARMACEUTICALS INC LIPO | Chancellor Michael B | 1,677,136 18.800% | 133,333 (+8.64%) | View |
| 2024-03-15 12:15 pm Purchase | 13D | LIPELLA PHARMACEUTICALS INC LIPO | Chancellor Michael B | 1,543,803 20.000% | 144,906 (+10.36%) | View |
| 2024-03-06 5:03 pm Purchase | 13D | LIPELLA PHARMACEUTICALS INC LIPO | Chancellor Michael B | 1,398,897 18.900% | 86,666 (+6.60%) | View |
| 2023-06-21 5:07 pm Purchase | 13D | LIPELLA PHARMACEUTICALS INC LIPO | Chancellor Michael B | 1,312,231 20.800% | 112,834 (+9.41%) | View |
| 2022-12-29 5:18 pm Purchase | 13D | LIPELLA PHARMACEUTICALS INC LIPO | Chancellor Michael B | 1,199,397 19.300% | 1,199,397 (New Position) | View |